These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15749920)

  • 41. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repertoire requirements of CD4+ T cells that prevent spontaneous autoimmune encephalomyelitis.
    Olivares-Villagómez D; Wensky AK; Wang Y; Lafaille JJ
    J Immunol; 2000 May; 164(10):5499-507. PubMed ID: 10799918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
    Krakowski ML; Owens T
    Eur J Immunol; 1997 Nov; 27(11):2840-7. PubMed ID: 9394808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
    Lees JR; Iwakura Y; Russell JH
    J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of IL-12 in the induction of intravenous tolerance in experimental autoimmune encephalomyelitis.
    Zhang GX; Xu H; Kishi M; Calida D; Rostami A
    J Immunol; 2002 Mar; 168(5):2501-7. PubMed ID: 11859144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.
    Chen Y; Kuchroo VK; Inobe J; Hafler DA; Weiner HL
    Science; 1994 Aug; 265(5176):1237-40. PubMed ID: 7520605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).
    Kumar V; Stellrecht K; Sercarz E
    J Exp Med; 1996 Nov; 184(5):1609-17. PubMed ID: 8920851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation.
    Casares S; Zong CS; Radu DL; Miller A; Bona CA; Brumeanu TD
    J Exp Med; 1999 Aug; 190(4):543-53. PubMed ID: 10449525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2.
    Nicolson K; Freland S; Weir C; Delahunt B; Flavell RA; Bäckström BT
    Int Immunol; 2002 Aug; 14(8):849-56. PubMed ID: 12147621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.
    Olivares-Villagómez D; Wang Y; Lafaille JJ
    J Exp Med; 1998 Nov; 188(10):1883-94. PubMed ID: 9815266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential activation of ERK, p38, and JNK required for Th1 and Th2 deviation in myelin-reactive T cells induced by altered peptide ligand.
    Singh RA; Zhang JZ
    J Immunol; 2004 Dec; 173(12):7299-307. PubMed ID: 15585853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.
    Racke MK; Bonomo A; Scott DE; Cannella B; Levine A; Raine CS; Shevach EM; Röcken M
    J Exp Med; 1994 Nov; 180(5):1961-6. PubMed ID: 7525845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD8 alpha coreceptor to improve TCR gene transfer to treat melanoma: down-regulation of tumor-specific production of IL-4, IL-5, and IL-10.
    Willemsen RA; Sebestyén Z; Ronteltap C; Berrevoets C; Drexhage J; Debets R
    J Immunol; 2006 Jul; 177(2):991-8. PubMed ID: 16818755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of IFN-gamma in the production of Th2 subpopulations: implications for variable Th2-mediated pathologies in autoimmunity.
    Wensky A; Marcondes MC; Lafaille JJ
    J Immunol; 2001 Sep; 167(6):3074-81. PubMed ID: 11544291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune disease.
    Ho PP; Fontoura P; Platten M; Sobel RA; DeVoss JJ; Lee LY; Kidd BA; Tomooka BH; Capers J; Agrawal A; Gupta R; Zernik J; Yee MK; Lee BJ; Garren H; Robinson WH; Steinman L
    J Immunol; 2005 Nov; 175(9):6226-34. PubMed ID: 16237121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα.
    Nuro-Gyina PK; Rieser EL; Granitto MC; Pei W; Liu Y; Lee PW; Aqel S; Zhang J; Lovett-Racke AE; Racke MK; Yang Y
    J Neuroinflammation; 2016 Dec; 13(1):302. PubMed ID: 27912762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
    Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice.
    Nagelkerken L; Blauw B; Tielemans M
    Int Immunol; 1997 Sep; 9(9):1243-51. PubMed ID: 9310827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
    Saoudi A; Simmonds S; Huitinga I; Mason D
    J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.
    Kuchroo VK; Das MP; Brown JA; Ranger AM; Zamvil SS; Sobel RA; Weiner HL; Nabavi N; Glimcher LH
    Cell; 1995 Mar; 80(5):707-18. PubMed ID: 7534215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.